|
|
Volumn 3, Issue 8, 2012, Pages 630-631
|
|
Erratum: The top prescription drugs of 2009-201 (ACS Chemical Neuroscience (2011) 3:8 (630-631) DOI:10.1021/cn3000923);The top prescription drugs of 2011 in the United States: Antipsychotics and antidepressants once again lead CNS therapeutics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALPRAZOLAM;
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
ATORVASTATIN;
ATVIAN;
CITALOPRAM;
CLOPIDOGREL;
DIAZEPAM;
DULOXETINE;
ESCITALOPRAM;
ESOMEPRAZOLE;
FLUOXETINE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
GENERIC DRUG;
LORAZEPAM;
MONTELUKAST;
NEUROLEPTIC AGENT;
OLANZAPINE;
PRESCRIPTION DRUG;
QUETIAPINE;
ROSUVASTATIN;
SERTRALINE;
SIMVASTATIN;
TRAZODONE;
UNCLASSIFIED DRUG;
ANXIETY DISORDER;
ATTENTION DEFICIT DISORDER;
BIPOLAR DISORDER;
CHRONIC DISEASE;
DEPRESSION;
DRUG CLASSIFICATION;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
EDITORIAL;
FIBROMYALGIA;
HUMAN;
MEDICAL LITERATURE;
MULTIPLE SCLEROSIS;
OBSESSIVE COMPULSIVE DISORDER;
PANIC;
PATENT;
POSTTRAUMATIC STRESS DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED STATES;
|
|
EID: 84865064185
PISSN: None
EISSN: 19487193
Source Type: Journal
DOI: 10.1021/cn400178w Document Type: Erratum |
|
Times cited : (50)
|
|
References (4)
|
